To include your compound in the COVID-19 Resource Center, submit it here.

Gammagard Liquid 10%: Completed Phase III enrollment

Baxter completed enrollment of 390 AD patients ages 50-89 in a double-blind, placebo-controlled, U.S.

Read the full 140 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE